Literature DB >> 25074354

Preference elicitation tool for abnormal uterine bleeding treatment: a randomized controlled trial.

Lisa M Hess1, Abigail Litwiller, John Byron, John Stutsman, Kelly Kasper, Lee A Learman.   

Abstract

BACKGROUND: It is estimated that one-third of women will experience abnormal menstrual bleeding. The majority of these cases are not due to cancer or pregnancy complications and, as a result, women are faced with a variety of treatment alternatives, the selection of which is largely dependent on personal preferences for care rather than clinical outcomes.
OBJECTIVE: This randomized trial was designed to evaluate a preference elicitation tool to promote physician-patient collaborative decision making for treatment of abnormal uterine bleeding (AUB).
METHODS: Adaptive conjoint analysis (ACA) was used to create a preference elicitation tool in English and in Spanish. Women with AUB were enrolled to the study and randomly assigned to ACA or usual counseling at the initial clinic visit at four clinics (three in Indianapolis, IN, USA, and one in Southern Pines, NC, USA). The ACA tool elicited preferences across eight attributes: treatment efficacy; sexual function; medical care; cost; fertility; frequency of medication use; permanence; and recovery time. t tests were used to compare differences in the primary outcomes of decision regret and treatment satisfaction at the follow-up visit. The study was designed to have 80 % power to detect significant differences between groups for the primary outcomes of regret and satisfaction.
RESULTS: Women were enrolled in the study between September 2009 and March 2012. 183 participants were randomized to ACA and 191 to usual counseling. Overall, mean (standard deviation) treatment satisfaction was high at 35.71 (9.72) (scale of 0-44), and decision regret was low at 25.9 (21.0) (scale of 0-100), creating ceiling effects for the selected outcome variables; there were no significant differences between the ACA and control groups at the follow-up assessment. There was a strong inverse relationship between age and decision regret (p = 0.007). Exploratory subgroup analysis in the youngest quartile comprising 64 women aged 19-35 years showed a statistically non-significant difference in mean regret scores for the ACA group versus usual counseling (24.6 vs. 34.6, respectively; p = 0.08).
CONCLUSIONS: A preference elicitation tool at the initial consultation visit did not reduce decision regret or improve treatment satisfaction among patients with AUB; however, there is a need for additional research to further understand this tool's potential role in promoting collaborative decision making, which may be particularly important among younger women.

Entities:  

Mesh:

Year:  2015        PMID: 25074354     DOI: 10.1007/s40271-014-0078-8

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  13 in total

Review 1.  A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding.

Authors:  Zhimei Liu; Quan V Doan; Paul Blumenthal; Robert W Dubois
Journal:  Value Health       Date:  2007 May-Jun       Impact factor: 5.725

2.  Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women.

Authors: 
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

3.  FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age.

Authors:  Malcolm G Munro; Hilary O D Critchley; Michael S Broder; Ian S Fraser
Journal:  Int J Gynaecol Obstet       Date:  2011-02-22       Impact factor: 3.561

4.  Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.

Authors:  Shannon N Westin; Charlotte C Sun; Karen H Lu; Kathleen M Schmeler; Pamela T Soliman; Robin A Lacour; Kristin G Johnson; Molly S Daniels; Banu K Arun; Susan K Peterson; Diane C Bodurka
Journal:  Cancer       Date:  2010-12-29       Impact factor: 6.860

5.  The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata.

Authors:  James B Spies; Karin Coyne; Noureddine Guaou Guaou; Deneane Boyle; Kerry Skyrnarz-Murphy; Sheila M Gonzalves
Journal:  Obstet Gynecol       Date:  2002-02       Impact factor: 7.661

6.  Validation of a decision regret scale.

Authors:  Jamie C Brehaut; Annette M O'Connor; Timothy J Wood; Thomas F Hack; Laura Siminoff; Elisa Gordon; Deb Feldman-Stewart
Journal:  Med Decis Making       Date:  2003 Jul-Aug       Impact factor: 2.583

7.  Improving informed decision-making for patients with knee pain.

Authors:  Liana Fraenkel; Nicole Rabidou; Dick Wittink; Terri Fried
Journal:  J Rheumatol       Date:  2007-08-01       Impact factor: 4.666

8.  A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage.

Authors:  Anna V Longacre; Avlin Imaeda; Guadalupe Garcia-Tsao; Liana Fraenkel
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  Computer-based decision making in medicine: A model for surgery of colorectal liver metastases.

Authors:  B S Langenhoff; P F M Krabbe; T J M Ruers
Journal:  Eur J Surg Oncol       Date:  2007-11-28       Impact factor: 4.424

10.  The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them?

Authors:  Malcolm G Munro; Hilary O D Critchley; Ian S Fraser
Journal:  Am J Obstet Gynecol       Date:  2012-02-08       Impact factor: 8.661

View more
  1 in total

1.  Clarifying Values: An Updated and Expanded Systematic Review and Meta-Analysis.

Authors:  Holly O Witteman; Ruth Ndjaboue; Gratianne Vaisson; Selma Chipenda Dansokho; Bob Arnold; John F P Bridges; Sandrine Comeau; Angela Fagerlin; Teresa Gavaruzzi; Melina Marcoux; Arwen Pieterse; Michael Pignone; Thierry Provencher; Charles Racine; Dean Regier; Charlotte Rochefort-Brihay; Praveen Thokala; Marieke Weernink; Douglas B White; Celia E Wills; Jesse Jansen
Journal:  Med Decis Making       Date:  2021-10       Impact factor: 2.583

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.